Financials Gelesis Holdings, Inc. Nyse

Equities

CPSR

US36850R2040

Pharmaceuticals

Market Closed - Nyse 10:04:16 2024-03-20 am EDT 5-day change 1st Jan Change
0.0198 USD +1,979,900.00% Intraday chart for Gelesis Holdings, Inc. +1,299,900.00% -99.61%

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 350.2 343.6 21.21
Enterprise Value (EV) 1 314.5 381.5 76.06
P/E ratio -0.58 x -0.12 x -0.21 x
Yield - - -
Capitalization / Revenue 16,331,266 x 30,721,502 x 823,104 x
EV / Revenue 14,667,009 x 34,107,465 x 2,951,835 x
EV / EBITDA -12.4 x -4.7 x -0.65 x
EV / FCF -5,818,178 x -14,472,039 x -1,297,882 x
FCF Yield -0% -0% -0%
Price to Book -0.15 x -0.07 x -0.85 x
Nbr of stocks (in thousands) 34,500 34,500 73,034
Reference price 2 10.15 9.960 0.2904
Announcement Date 11/9/21 5/24/22 3/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales - 21.44 11.18 25.77
EBITDA 1 -29.62 -25.45 -81.18 -116.3
EBIT 1 -31.21 -28.22 -84.97 -121.8
Operating Margin - -131.63% -759.7% -472.72%
Earnings before Tax (EBT) 1 -28.37 -23.87 -93.33 -55.3
Net income 1 -22.96 -25.9 -93.35 -55.78
Net margin - -120.81% -834.57% -216.48%
EPS 2 -5.926 -17.61 -85.22 -1.352
Free Cash Flow - -54.05 -26.36 -58.6
FCF margin - -252.09% -235.68% -227.43%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 11/9/21 11/9/21 5/24/22 3/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -12.51
Net margin -
EPS 2 -0.1700
Dividend per Share -
Announcement Date 8/15/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 - - 37.9 54.9
Net Cash position 1 29.3 35.7 - -
Leverage (Debt/EBITDA) - - -0.4665 x -0.4716 x
Free Cash Flow - -54.1 -26.4 -58.6
ROE (net income / shareholders' equity) - -45.5% -257% 592%
ROA (Net income/ Total Assets) - -14.5% -34.2% -61%
Assets 1 - 178.3 272.6 91.45
Book Value Per Share 2 -56.20 -68.20 -137.0 -0.3400
Cash Flow per Share 2 16.90 22.30 11.80 0.1000
Capex 1 10.5 32.2 19.9 9.12
Capex / Sales - 150.23% 178.07% 35.39%
Announcement Date 11/9/21 11/9/21 5/24/22 3/28/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GLSH.Q Stock
  4. CPSR Stock
  5. Financials Gelesis Holdings, Inc.